Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-77242113 oral bioavailability and food-effect formulation study in healthy adults
NL-OMON52057Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of icotrokinra in Inflammatory Disorders (5 arms), sponsored by Janssen Pharmaceutical. Started Oct 2021; status: active, not recruiting.
02
Drugs
icotrokinra
03
Conditions
Inflammatory Disorders
Beyond the preview
Go deeper on NL-OMON52057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52057.